Navigation Links
Defectors take the car, cooperators go by bus
Date:2/3/2009

National economies are driven by the automobile, even during an economic downturn. Every day, hundreds of millions of people take their cars to visit remote places, to commute, and to reach the supermarket.

The total outlay for building roads amounts to trillions of dollars and millions of worker-hours. Miklos Szilagyi of the University of Arizona, Tucson suggests this is an apparent waste of resources, a serious producer of pollution, congestion, delays, and the fundamental reason for US dependence on foreign oil, but is mass transportation in large cities the best alternative. Should commuters take the bus rather than driving to work?

Writing in a forthcoming issue of the International Journal of the Internet and Enterprise Management, Szilagyi has used a computer simulation to help answer the transport dilemma of facing large cities.

The received wisdom suggests that the answer lies with public transportation. "If there were no cars but reliable trains and buses, everyone could get anywhere quickly and without traffic jams," says Szilagyi. His simulation greatly simplifies the issues, but works by considering each person to be cooperating if they use public transportation or defect if they selfishly choose to take their care. The decisions of all the individuals using the roads cooperatively or in defecting will accumulate over time to produce a collective order that will determine the success or failure of the transportation system.

If everyone defects, then there will be permanent gridlock. But, even if a few individuals choose the bus, this will not help, because the buses will also be gridlocked. Defectors and cooperators are both punished for the irresponsible behavior of the majority.

In contrast, if everyone uses the bus, the buses will be crowded although can move freely on otherwise empty streets. Everyone gets to their destination quickly but in less comfort and without the benefits of priva
'/>"/>

Contact: Miklos Szilagyi
mns171717@yahoo.com
520-577-9275
Inderscience Publishers
Source:Eurekalert

Page: 1 2

Related biology news :

1. New southernpeas developed by ARS, cooperators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Alzheimers and Even Mild Dementia Hasten Death 48350 1Alzheimers and Even Mild Dementia Hasten Death 48350 2Colon cancer screening technique shows continued promise in new study 8770 1Colon cancer screening technique shows continued promise in new study 8770 2Families Consumers of Home Care Impacted by Budget Cuts to Hold Noon Vigil Outside Fresno Board of Supervisors Meeting as Clock Ticks Down to July 1s 48342 1Families Consumers of Home Care Impacted by Budget Cuts to Hold Noon Vigil Outside Fresno Board of Supervisors Meeting as Clock Ticks Down to July 1s 48342 2
...rgo, Fla. April 27, 2009 A new study appearing i...e for reattaching large sponges that have been dis...erally applied to the restoration of other large s... events. , 20 specimens of the Caribbean giant ba...eef off of Key Largo, Florida in 2004 and 2005 at ...
... (April 27, 2009) In an in vitro study, led by Gra... researchers discovered how a protein called SUMO ...e complex that alters the structure of chromatin t...pacted mass of DNA and protein that make up chromo... complex is of interest in the study of cancer and...
...N, WI, APRIL 27, 2009 Landfilled waste decomposes...ction of methane. Landfills are classified as the .... Additionally, landfill gas contains numerous non...directly from waste materials or produced through ... Microbial methane oxidation reduces the emissions...
Other Biology News:Large sponges may be reattached to coral reefs 2SUMO protein guides chromatin remodeler to suppress genes 2Landfill cover soil methane oxidation underestimated 2
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)The Scientist, a leading scientific magazine covering the life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among the publication’s “Top 10 Inn
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
... Inc. (Nasdaq: INSM ), a developer of follow-on ...that Dr. Geoffrey Allan, President and CEO of Insm... Biosimilars Long View Conference on December 3, 2...nference is to better educate the investment commu...rence will be split into several tracks examining ...
...er announced today,that its flagship product Scopu...ase of peer-reviewed literature, will be nearly do... Access to the new journals will be available to,S...tabase contains 1,600,titles in A&H and relate...presented as a result of these added,titles and re...
...stic Imaging will produce its,11th Annual Webcast ...ng,Radiology Society of North America Scientific A..., IL, from November 30th through December 5th. Th... events taking place and will,be available on Diag...wers the opportunity to join our team of editors a...
Other Biology Technology:Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference 2Scopus to Expand Arts & Humanities Coverage 2Scopus to Expand Arts & Humanities Coverage 3Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008 2
Mouse Anti-nicotinic Acetylcholine Receptor Monoclonal Antibody, Unconjugated, Clone 88B from Abcam
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Mouse Anti-Secretory Component Glycoprotein Monoclonal Antibody, Unconjugated, Clone SPM217 from Abcam
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: